Protalix Biotherapeutics Stock Forward View
| PLX Stock | USD 2.06 0.06 2.83% |
Protalix Stock outlook is based on your current time horizon.
At this time, The value of RSI of Protalix Biotherapeutics' share price is at 51 indicating that the stock is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling Protalix Biotherapeutics, making its price go up or down. Momentum 51
Impartial
Oversold | Overbought |
Using Protalix Biotherapeutics hype-based prediction, you can estimate the value of Protalix Biotherapeutics from the perspective of Protalix Biotherapeutics response to recently generated media hype and the effects of current headlines on its competitors.
The Naive Prediction forecasted value of Protalix Biotherapeutics on the next trading day is expected to be 2.06 with a mean absolute deviation of 0.05 and the sum of the absolute errors of 2.99. Protalix Biotherapeutics after-hype prediction price | USD 0.0 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Protalix Biotherapeutics to cross-verify your projections. Protalix Biotherapeutics Additional Predictive Modules
Most predictive techniques to examine Protalix price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Protalix using various technical indicators. When you analyze Protalix charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Protalix Biotherapeutics Naive Prediction Price Forecast For the 30th of January
Given 90 days horizon, the Naive Prediction forecasted value of Protalix Biotherapeutics on the next trading day is expected to be 2.06 with a mean absolute deviation of 0.05, mean absolute percentage error of 0, and the sum of the absolute errors of 2.99.Please note that although there have been many attempts to predict Protalix Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Protalix Biotherapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Protalix Biotherapeutics Stock Forecast Pattern
| Backtest Protalix Biotherapeutics | Protalix Biotherapeutics Price Prediction | Buy or Sell Advice |
Protalix Biotherapeutics Forecasted Value
In the context of forecasting Protalix Biotherapeutics' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Protalix Biotherapeutics' downside and upside margins for the forecasting period are 0.02 and 5.23, respectively. We have considered Protalix Biotherapeutics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Protalix Biotherapeutics stock data series using in forecasting. Note that when a statistical model is used to represent Protalix Biotherapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 112.5855 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.049 |
| MAPE | Mean absolute percentage error | 0.0258 |
| SAE | Sum of the absolute errors | 2.9896 |
Predictive Modules for Protalix Biotherapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Protalix Biotherapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Protalix Biotherapeutics After-Hype Price Density Analysis
As far as predicting the price of Protalix Biotherapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Protalix Biotherapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Protalix Biotherapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Protalix Biotherapeutics Estimiated After-Hype Price Volatility
In the context of predicting Protalix Biotherapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Protalix Biotherapeutics' historical news coverage. Protalix Biotherapeutics' after-hype downside and upside margins for the prediction period are 0.00 and 3.17, respectively. We have considered Protalix Biotherapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Protalix Biotherapeutics is out of control at this time. Analysis and calculation of next after-hype price of Protalix Biotherapeutics is based on 3 months time horizon.
Protalix Biotherapeutics Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Protalix Biotherapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Protalix Biotherapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Protalix Biotherapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.18 | 3.17 | 0.00 | 0.07 | 0 Events / Month | 1 Events / Month | Within a week |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
2.06 | 0.00 | 0.00 |
|
Protalix Biotherapeutics Hype Timeline
On the 29th of January Protalix Biotherapeutics is traded for 2.06. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.07. Protalix is expected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is expected to be very small, whereas the daily expected return is at this time at -0.18%. %. The volatility of related hype on Protalix Biotherapeutics is about 788.56%, with the expected price after the next announcement by competition of 2.13. About 18.0% of the company shares are owned by institutional investors. The book value of Protalix Biotherapeutics was at this time reported as 0.66. The company last dividend was issued on the 20th of December 2019. Protalix Biotherapeutics had 1:10 split on the 20th of December 2019. Considering the 90-day investment horizon the next expected press release will be within a week. Check out Historical Fundamental Analysis of Protalix Biotherapeutics to cross-verify your projections.Protalix Biotherapeutics Related Hype Analysis
Having access to credible news sources related to Protalix Biotherapeutics' direct competition is more important than ever and may enhance your ability to predict Protalix Biotherapeutics' future price movements. Getting to know how Protalix Biotherapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Protalix Biotherapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| SLS | Sellas Life Sciences | 0.00 | 0 per month | 4.95 | 0.20 | 14.94 | (7.41) | 34.72 | |
| CHRS | Coherus BioSciences | 0.00 | 0 per month | 5.17 | 0.09 | 10.34 | (7.35) | 41.11 | |
| IVVD | Invivyd | 0.00 | 0 per month | 5.78 | 0.04 | 11.11 | (8.57) | 46.37 | |
| TARA | Protara Therapeutics | 0.00 | 0 per month | 5.00 | 0.1 | 11.78 | (8.67) | 39.96 | |
| GNFT | Genfit SA | 0.00 | 0 per month | 3.68 | 0.18 | 8.47 | (7.71) | 25.18 | |
| CDXS | Codexis | 0.00 | 0 per month | 0.00 | (0.19) | 5.66 | (8.20) | 22.77 | |
| OABI | OmniAb Inc | 0.00 | 0 per month | 2.60 | 0.08 | 7.97 | (5.31) | 15.55 | |
| NTHI | NeOnc Technologies Holdings | 4.02 | 6 per month | 7.95 | 0.01 | 9.99 | (11.89) | 41.97 | |
| MDWD | Mediwound | 0.00 | 0 per month | 0.00 | (0.04) | 3.79 | (4.40) | 14.07 | |
| SGMO | Sangamo Therapeutics | 0.00 | 0 per month | 0.00 | (0.01) | 8.51 | (6.98) | 21.14 |
Other Forecasting Options for Protalix Biotherapeutics
For every potential investor in Protalix, whether a beginner or expert, Protalix Biotherapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Protalix Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Protalix. Basic forecasting techniques help filter out the noise by identifying Protalix Biotherapeutics' price trends.Protalix Biotherapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Protalix Biotherapeutics stock to make a market-neutral strategy. Peer analysis of Protalix Biotherapeutics could also be used in its relative valuation, which is a method of valuing Protalix Biotherapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Protalix Biotherapeutics Market Strength Events
Market strength indicators help investors to evaluate how Protalix Biotherapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Protalix Biotherapeutics shares will generate the highest return on investment. By undertsting and applying Protalix Biotherapeutics stock market strength indicators, traders can identify Protalix Biotherapeutics entry and exit signals to maximize returns.
Protalix Biotherapeutics Risk Indicators
The analysis of Protalix Biotherapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Protalix Biotherapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting protalix stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.33 | |||
| Standard Deviation | 3.17 | |||
| Variance | 10.08 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Protalix Biotherapeutics
The number of cover stories for Protalix Biotherapeutics depends on current market conditions and Protalix Biotherapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Protalix Biotherapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Protalix Biotherapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Protalix Biotherapeutics Short Properties
Protalix Biotherapeutics' future price predictability will typically decrease when Protalix Biotherapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Protalix Biotherapeutics often depends not only on the future outlook of the potential Protalix Biotherapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Protalix Biotherapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 81.1 M | |
| Cash And Short Term Investments | 34.8 M |
Additional Tools for Protalix Stock Analysis
When running Protalix Biotherapeutics' price analysis, check to measure Protalix Biotherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Protalix Biotherapeutics is operating at the current time. Most of Protalix Biotherapeutics' value examination focuses on studying past and present price action to predict the probability of Protalix Biotherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Protalix Biotherapeutics' price. Additionally, you may evaluate how the addition of Protalix Biotherapeutics to your portfolios can decrease your overall portfolio volatility.